Marcos-Villar L, Fernando Lopitz-Otsoa F, Gallego P, Muñoz-Fontela C, González-Santamaría J, Campagna M, Gao SJ, Rodriguez M and Rivas C. KSHV protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of Survivin gene.
Journal of Virology, published ahead of print on 24 June 2009.
Greene W and Gao S-J*. Actin dynamics regulate clathrin-mediated endocytosis during Kaposi’s sarcoma-associated herpesvirus entry into endothelial cells. PLoS Pathogens, 2009, 5(7): e1000512.
Fu BS, Sun F, Li BL, Yang L, Zeng Y, Sun XL, Xu FH, Rayner S, Gao S-J* and Wang L-D*. Kaposi’s sarcoma-associated herpesvirus seroprevalence, risk factors and genotypes in Xinjiang, China.
Journal of Medical Virology, 2009, 23, 1422-1431.
Meng J, Gao S-J, Huang YF. Enrichment constrained time-dependent clustering analysis for finding meaningful temporal transcription modules. Bioinformatics, 2009,25, 1521-1527.
Chen JG, Ye FC, Xie JP, Kuhne, K and Gao S-J*. Genome-wide identification of binding sites for Kaposi’s sarcoma-associated herpesvirus lytic switch protein, RTA.
Virology, 2009, 386, 290-302.
Zhou FC, Li QH, Gao S-J*. A sequence-independent in vitro transposon-based strategy for efficient cloning of genomes of large DNA viruses as bacterial artificial chromosomes.
Nucleic Acid Research, 2009, 37:e2.
Qian LW, Greene W, Ye FC and Gao S-J*. Kaposi’s sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin.
Journal of Virology, 2008, 82, 11902-12.
Li QH, Zhou FC, Ye FC, Gao S-J*. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology, 2008, 379, 234-244.
Meng J, Gao S-J, Huang YF. An Iterative time window signature algorithm for time-dependent transcription module discovery. IEEE Workshop Genomic Signal Processing and Statistics (GENSiPS), 2008, 1-4.
Liu H, Yue D, Zhang L, Gao S-J, Huang YF. A machine learning approach for miRNA target prediction. IEEE Workshop Genomic Signal Processing and Statistics (GENSiPS), 2008, 1-3.
Ye FC, Zhou FC, Xie JP, Kang T, Greene W, Kuhne K, Lei XF, Li QH, Gao S-J*. Kaposi’s sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.
Journal of Virology, 2008, 82, 4235-4249.
Xie JP, Ajibade AO, Ye FC, Kuhne K and Gao S-J*. MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways are essential for the reactivation of Kaposi’s sarcoma-associated herpesvirus from latency. Virology, 2008, 371, 139-154.
Kang T, Ye FC, Wang LD and Gao S-J*. Angiogenesis, Kaposi’s sarcoma and Kaposi’s sarcoma-associated herpesvirus.
Virologica Sinica, 2008, 23, 449-458.
Bai ZQ, Lei XF, Wang LD* and Gao S-J*. Identification and function of microRNAs encoded by herpesviruses.
Virologica Sinica, 2008, 23, 459-472.
Muñoz-Fontela C, Villar LM, Hernandez F, Gallego P, Rodriguez E, Arroyo J, Gao S-J, Avila J, Rivas M. Induction of paclitaxel resistance by the KSHV latent protein LANA2.
Journal of Virology, 2008, 82, 1518-1525.
Cloutier N, Eyll OV, Lefort S, Janelle M-E, Gao S-J, Flamand L. Development of a mouse model for the identification of HHV-8 genes contributing to tumorigenesis.
Archives of Virology. 2008, 153, 93-103.
Qian LW, Xie JP, Ye FC and Gao S-J*. Kaposi’s sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases.
Journal of Virology, 2007, 81, 7001-7010.
Nun T, Kroll DJ, Oberlies NH, Soejarto DD, Case R, Piskaut P, Matainaho T, Hilscher C, Wang L, Dittmer DP, GaoS-J and Damania B. Development of a fluorescence-based assay to screen antiviral drugs against Kaposi’s sarcoma-associated herpesvirus.
Molecular Cancer Therapeutics, 2007, 6, 2360-2370.
Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Asgari Z, Hooper AT, La Perle KMD, Hilsher C, Gao S-J, Dittmer D, Rafii S and Mesri EA. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma.
Cancer Cell, 2007, 11, 245-258.
Greene W, Kuhne K, Ye FC, Chen JG, Zhou FC, Lei XF, and Gao S-J*. Molecular biology of KSHV in relation to AIDS-associated oncogenesis. In: AIDS-Associated Viral Oncogenesis, Cancer Treatment and Research Book Series. Volume 133, 2007, pp: 69-127. Craig Meyers (Ed.). Springer US Science+Business Media. 978-0-387-46816-7 (Online) ISBN: 978-0-387-46804-4 (Print). (Review and Comments in New England Journal of Medicine 2008, 358, 98).
Ye FC, Blackbourn DJ, Mengel M, Xie JP, Qian LW, Greene W, Yeh I-T, Graham D, and Gao S-J*. Kaposi’s sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1.
Journal of Virology, 2007, 81, 3980-3991.
Majerciak M, Pripuzova N, McCoy JP, Gao S-J and Zheng Z-M. Targeted disruption of KSHV ORF57 in the viral genome is detrimental for the expression of ORF59, K8, and K8.1 and the production of infectious virus. Journal of Virology, 2007, 81, 1062-1071.